MENU
CAPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Capricor Therapeutics (CAPR) Ownership - Who owns Capricor Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
569.74M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
2.02M
Revenue
N/A
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.73 USD as % of share price
Fundamentals
CAPR
Capitalization
570M
P/E Ratio
N/A
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
2.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.73%
Revenue
N/A
ROE
N/A
Book Value
18.4M
P/B Ratio
8.35
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31.6K
Current Ratio
1.57
Current Revenue Per Employee
48106.64
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
91.3M
Shares Outstanding - Current
45.5M
Total Liabilities
31M
Total Volume MTD
N/A
Value
-1
Gain YTD
156.033
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Develops innovative products for the treatment of cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com